Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Advanced Cancer
- Sarcoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03242382
- Collaborators
- Not Provided
- Investigators
- Study Director: Javier Martin Broto, MD Hospitales Universitarios Virgen del Rocío Study Director: Roberto Díaz, MD Hospital Universitario La Fe Principal Investigator: Javier Martínez Trufero, MD Hospital Miguel Servet Principal Investigator: Yolanda Vidal, MD Complejo Hospitalario Universitario de Santiago Principal Investigator: Carlos Alvarez, MD Hospital Universitario Central de Asturias Principal Investigator: Antonio López-Pousa, MD Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Principal Investigator: José Antonio López-Martín, MD Hospital Universitario 12 de Octubre Principal Investigator: Isabel Sevilla, MD Hospital Universitario Virgen de la Victoria
Get Well Soon